Outcome after breast cancer in Singapore and Malaysia

Breast cancer patients from Singapore and Malaysia have substantial differences in terms of overall survival which are not completely explained by tumor characteristics and treatment differences. Elderly Singaporean patients present with more advanced disease and are less likely to receive adequate treatment compared to younger Singaporean patients. Singaporean patients overall still have some way to go before they can achieve survival rates seen for the SEER (USA) patients which can partly be achieved by early detection / presentation. Lastly, based on the results from the Lymph Node Ratio (LNR) studies, it is clear that LNR does not add any prognostic value over the current nodal staging system for patients from Singapore and Malaysia.

Author dc:creator

• NAKUL SAXENA

• breast cancer, survival, prognosis, Singapore, Malaysia